DRIVIN G ROWTH - Dr. Reddy's

The highlights of the scheme were:
■ It was applicable to all permanent workmen
who had completed 10 years of service or 40
years of age.
■ Managerial staff and Directors were not
covered in this scheme.
■ The VRS benefits paid to the workmen whose
applications were accepted were lower of
either three months salary (basic + dearness
allowance) for each completed year of service,
or salary (basic + dearness allowance)
multiplied by the remaining months of service
left before normal date of retirement, subject
to maximum of Rs. 300,000.
Dr. Reddy’s has paid Rs. 20.5 millions
towards the retirement compensation in
this scheme.
financials
BALANCE SHEET
Table 6
|
Summarised Balance Sheet
RS. MILLION
MARCH 31, 2002 MARCH 31, 2001
Sources of Funds
Shareholder’s funds 14,579.9 5,532.6
Loan Funds 138.2 3,754.4
Total of Sources of funds 14,718.1 9,287.0
Application of Funds
Fixed Assets 3,959.6 3,310.1
Investments
Current Assets,
639.4 789.8
Loans and Advances
Current liabilities
12,560.3 5,618.3
and provisions (2,006.3) (1,376.8)
Net Current Assets 10,554.0 4,241.5
Deferred tax liability
Miscellaneous Expenditure
(to the extent not
(434.9) –
written off or adjusted) – 945.6
Total of Application of Funds 14,718.1 9,287.0
SHARE CAPITAL
DURING 2001-02, Dr. Reddy’s became
first Asian pharmaceutical company
outside of Japan to list on the NYSE. This
provided the Company with access to the
world’s capital markets, gave it greater
international visibility, and raised the bar
of compliance with global regulatory
standards.
On October 25, 2001, each equity shares
of Rs. 10/- was subdivided into two equity
shares of Rs. 5/- each, pursuant to the
DR. REDDY’S LABORATORIES LTD. | MANAGEMENT DISCUSSION AND ANALYSIS | ANNUAL REPORT 2001-2002
59